ACOG Releases New Guidance on GLP-1 Medications During Pregnancy and Lactation

Given limited safety data, ACOG recommends discontinuing these medications 1-2 months before conception and avoiding their use during pregnancy. During breastfeeding, the guidance supports shared decision-making and close monitoring of infant weight gain, while advising against use when breastfeeding preterm infants or newborns. Explore the full practice advisory here.